CLINICAL AND IMMUNOLOGICAL CORRELATIONS IN PATIENTS WITH SYSTEMICLUPUS ERYTHEMATOSUS WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME
- Authors: Belolipetskaia EA1, Beliaeva IB1, Mazurov VI1, Trofimov EA1, Lapin SV2
-
Affiliations:
- North-Western State Medical university named after I.I. Mechnikov
- St. Petersburg State Medical university named after I.P. Pavlov
- Issue: Vol 9, No 3 (2017)
- Pages: 7-11
- Section: Reviews
- URL: https://journal-vniispk.ru/vszgmu/article/view/8574
- DOI: https://doi.org/10.17816/mechnikov2017937-11
- ID: 8574
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
E A Belolipetskaia
North-Western State Medical university named after I.I. Mechnikov
I B Beliaeva
North-Western State Medical university named after I.I. Mechnikov
V I Mazurov
North-Western State Medical university named after I.I. Mechnikov
E A Trofimov
North-Western State Medical university named after I.I. Mechnikov
S V Lapin
St. Petersburg State Medical university named after I.P. Pavlov
References
- Мазуров В.И. Ревматология. Фармакотерапия без ошибок: руководство для врачей под ред. В.И. Мазурова. - М.: Еното, 2017. - 528 c.
- Biggioggero M. The geoepidemiology of the antiphospholipid antibodysyndrome / M. Biggioggero, P.L. Meroni // Autoimmunity Reviews. - 2010. - Vol. 9. - № 5. - Р. A299304.
- Reynaud Q. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and metaanalysis / Q. Reynaud, J.C. Lega, P. Mismetti et al. // Autoimmunity Reviews. - 2014. - Vol. 13. - № 6. - P. 595608.
- Vlagea A. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome / A. Vlagea, A. Gil, M.V. Cuesta et al. // Clin. Appl. Thromb. Hemost. - 2013. - Vol. 19. - № 3. - P. 289296.
- Bizzaro N. Antiprothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15year longitudinal study / N. Bizzaro, A. Ghirardello, S. Zampieri et al. // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5. - № 6. - P. 11581164.
- Sciascia S. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities / S. Sciascia, V. Murru, G. Sanna et al. // Journal of Thrombosis and Haemostasis. - 2012. - Vol. 10. - № 12. - P. 25122518.
- Lakos G. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases / G. Lakos, E. Kiss, N. Regeczy et al. // J. Rheumatol. - 2000. - Vol. 27. - № 4. - P. 924929.
- Bertolaccini M.L. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE) / M.L. Bertolaccini, V. Murru, S. Sciascia et al. // Thrombosis Research. - 2012. - Vol. 130. - № 6. - P. 914918.
- Sanmarco M. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies / M. Sanmarco, S. Gayet, M.C. Alessi et al. // Thrombosis and Haemostasis. - 2007. - Vol. 97. - № 6. - P. 949954.
- Taraborelli M. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus / M. Taraborelli, M.G. Lazzaroni, N. Martinazzi et al. // Reumatismo. - 2016. - Vol. 68. - № 3. - P. 137143.
- Taraborelli M. The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus / M. Taraborelli, L. Leuenberger, M.G. Lazzaroni et al. // Lupus. - 2016. - Vol. 25. - № 12. - P. 13651368.
- Dima A. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients / A. Dima, S. Caraiola, C. Jurcut et al. // Romanian Journal of Internal Medicine. - 2015. - Vol. 53. - № 4. - P. 321328.
- Tektonidou M.G. Renal involvement in the antiphospholipid syndrome (APS)nephropathy // Clinical Reviews in Allergy and Immunology. - 2009. - Vol. 36. - № 23. - P. 131-140.
- Syuto T. Association of antiphosphatidylserine/prothrombin antibodies with neuropsychiatric systemic lupus erythematosus / T. Syuto, A. Shimizu, Y. Takeuchi et al. // Clinical Rheumatology. - 2009. - Vol. 28. - № 7. - P. 841845.
- Butkiewicz F. Associations between theincidence of antiphosphatidylserine and antiphosphatidylethanolamine antibodies and clinical manifestations of systemic lupus erythematosus / F. Butkiewicz, M. Kaszuba, M. Brzeziński et al. // Polish Archives of Internal Medicine. - 2014. - Vol. 124. - № 11. - P. 573578.
- Pierangeli S.S. Tolllike receptor and antiphospholipid mediated thrombosis: in vivo studies/ S.S. Pierangeli, M.E. VegaOstertag, E. Raschi et al. // Annals of the Rheumatic Diseases. - 2007. - Vol. 66. - № 10. - P. 13271333.
- Association between the valine/leucine247 polymorphism of b2glycoprotein I and susceptibility to antiphospholipid syndrome: a metaanalysis / Y.H. Lee, S.J. Choi, J.D. Ji, G.G. Song // Lupus. - 2012. - Vol. 21. - № 8. - P. 865871.
- Ames P.R. Impact of plasma homocysteine and prothrombin G20210 A on primary antiphospholipid syndrome / P.R. Ames, M. Margaglione, C. Tommasino et al. // Blood Coagulation and Fibrinolysis. - 2001. - Vol. 12. - № 8. - P. 699704.
- Pengo V. Incidence of a first thromboembolic event in asymptomatic carriers of highrisk antiphospholipid antibody profile: a multicenter prospective study/ V. Pengo, A. Ruffatti, C. Legnani et al. // Blood. - 2011. - Vol. 118. - № 17. - P. 47144718.
- Sciascia S. GAPSS: the Global AntiPhospholipid Syndrome Score / S. Sciascia, G. Sanna, V. Murru et al. // Rheumatology. - 2013. - Vol. 52. - № 8. - P. 13971403.
Supplementary files
